Page last updated: 2024-08-17

nadp and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

nadp has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Basso, G; Buldini, B; Cavallari, I; Ciccarese, F; Ciminale, V; Corradin, A; D'Agostino, DM; Francescato, S; Indraccolo, S; Kotler, H; Minuzzo, SA; Raimondi, V; Scattolin, G; Sharova, E; Silic-Benussi, M; Urso, L	1

Other Studies

1 other study(ies) available for nadp and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Article	Year
mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells. Redox biology, 2022, Volume: 51 Topics: Animals; Apoptosis; Cell Line, Tumor; Dexamethasone; Everolimus; Glucosephosphate Dehydrogenase; Humans; Mice; Mice, Inbred NOD; Mice, SCID; MTOR Inhibitors; NADP; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species; T-Lymphocytes; TOR Serine-Threonine Kinases	2022

Article

Year

mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells.

Redox biology, 2022, Volume: 51

Topics: Animals; Apoptosis; Cell Line, Tumor; Dexamethasone; Everolimus; Glucosephosphate Dehydrogenase; Humans; Mice; Mice, Inbred NOD; Mice, SCID; MTOR Inhibitors; NADP; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species; T-Lymphocytes; TOR Serine-Threonine Kinases

2022